(Q43276807)

18 November 2017

title

Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C. (English)

1 reference

18 November 2017

1 reference

1 reference

8

1 reference

18 November 2017

M-H Hsieh

1

1 reference

18 November 2017

C-K Ho

2

1 reference

18 November 2017

N-J Hou

3

1 reference

18 November 2017

M-Y Hsieh

4

1 reference

18 November 2017

W-Y Lin

5

1 reference

18 November 2017

J-F Yang

6

1 reference

18 November 2017

C-C Chiu

7

1 reference

18 November 2017

N-C Chang

9

1 reference

18 November 2017

C-L Wang

10

1 reference

18 November 2017

C-Y Dai

11

1 reference

18 November 2017

W-L Chuang

12

1 reference

18 November 2017

M-L Yu

13

1 reference

18 November 2017

language of work or name

English

0 references

publication date

15 September 2009

1 reference

International Journal of Obesity

18 November 2017

published in

1 reference

18 November 2017

volume

33

1 reference

18 November 2017

issue

11

1 reference

18 November 2017

page(s)

1309-1317

1 reference

Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

Cardiovascular morbidity and mortality associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Metabolic syndrome: a multiplex cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Significant correlations between severe fatty liver and risk factors for metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Metabolic syndrome in older people in Taiwan: a hospital-based study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Prevalence of obesity and metabolic syndrome in Taiwan.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

1. Fatty liver and non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

https://api.crossref.org/works/10.1038%2FIJO.2009.172

1 reference

7 January 2021

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

The clinical significance of persistently normal ALT in chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.172

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.172

1 reference

Dimensions Publication ID

18 November 2017

1036588218

0 references

1 reference